as of 03-23-2026 3:52pm EST
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 913.3M | IPO Year: | 2024 |
| Target Price: | $34.29 | AVG Volume (30 days): | 218.4K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.59 | EPS Growth: | 23.26 |
| 52 Week Low/High: | $21.21 - $42.29 | Next Earning Date: | 05-05-2026 |
| Revenue: | $551,589,000 | Revenue Growth: | 29.58% |
| Revenue Growth (this year): | 21.14% | Revenue Growth (next year): | 19.15% |
| P/E Ratio: | 13.63 | Index: | N/A |
| Free Cash Flow: | 326.0M | FCF Growth: | +11.97% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
SEC 8-K filings with transcript text
Feb 24, 2026 · 100% conf.
1D
+1.45%
$24.71
Act: +7.39%
5D
+6.81%
$26.02
Act: +2.01%
20D
+10.73%
$26.97
bow-202602240002002473false00020024732026-02-242026-02-24
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2026
Bowhead Specialty Holdings Inc. (Exact name of registrant as specified in its charter)
Delaware 001-42111 87-1433334
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
452 Fifth Avenue New York, New York 10018
(Address of principal executive offices)
(212) 970-0269
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: £ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) £ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) £ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) £ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share BOW New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 under the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company T If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. £
Item 2.02 Results of Operations and Financial Condition. On February 24, 2026, Bowhead Specialty Holdings Inc. (the "Company") issued a press release announcing its financial results for the three months and twelve months ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 7.01 Regulation FD Disclosure. On February 24, 2026, the Company made available to investors an investor presentation for the period ended December 31, 2025 (the "Investor Presentation"). The Investor Presentation is furnished as Exhibit 99.2 hereto. The Investor Presentation is also available on the Investors section of the Company's website, free of charge, at https://ir.bowheadspecialty.com.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Press Release of the Company, dated February 24, 2026
99.2 Bowhead Specialty Holdings Inc. Investor Presentation for the period ended December 31, 2025
104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: February 24, 2026
By: /s/Brad Mulcahey
Name: Brad Mulcahey
Title: Chief Financial Officer and Treasurer
Nov 4, 2025
bow-202511040002002473false00020024732025-11-042025-11-04
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2025
Bowhead Specialty Holdings Inc. (Exact name of registrant as specified in its charter)
Delaware 001-42111 87-1433334
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
452 Fifth Avenue New York, New York 10018
(Address of principal executive offices) (212) 970-0269
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: £ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) £ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) £ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) £ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareBOWNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 under the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company T If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. £
Item 2.02 Results of Operations and Financial Condition. On November 4, 2025, Bowhead Specialty Holdings Inc. (the "Company") issued a press release announcing its financial results for the three months ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 7.01 Regulation FD Disclosure. On November 4, 2025, the Company made available to investors a supplemental presentation containing the Company's results for the three months ended September 30, 2025. This investor presentation is furnished as Exhibit 99.2 hereto. The supplemental report is also available on the Investors section of the Company's website, free of charge, at https://ir.bowheadspecialty.com.
Item 9.01. Financial Statements and Exhibits. (d) Exhibits.
Exhibit No. Description 99.1Press Release of the Company, dated November 4, 2025
99.2Bowhead Specialty Holdings Inc. Investor Presentation for the period ended September 30, 2025
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: November 4, 2025
By:/s/ Brad Mulcahey Name:Brad Mulcahey Title:Chief Financial Officer and Treasurer
Aug 5, 2025
bow-202508050002002473false00020024732025-08-052025-08-05
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025
Bowhead Specialty Holdings Inc. (Exact name of registrant as specified in its charter)
Delaware 001-42111 87-1433334
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
452 Fifth Avenue New York, New York 10018
(Address of principal executive offices) (212) 970-0269
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: £ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) £ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) £ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) £ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per shareBOWNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 under the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company T If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. £
Item 2.02 Results of Operations and Financial Condition. On August 5, 2025, Bowhead Specialty Holdings Inc. (the "Company") issued a press release announcing its financial results for the three months ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 7.01 Regulation FD Disclosure. On August 5, 2025, the Company made available to investors a supplemental presentation containing the Company's results for the three months ended June 30, 2025. This investor presentation is furnished as Exhibit 99.2 hereto. The supplemental report is also available on the Investors section of the Company's website, free of charge, at https://ir.bowheadspecialty.com.
Item 9.01. Financial Statements and Exhibits. (d) Exhibits.
Exhibit No. Description 99.1Press Release of the Company, dated August 5, 2025
99.2Bowhead Specialty Holdings Inc. Investor Presentation for the period ended June 30, 2025
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 5, 2025
By:/s/ Brad Mulcahey Name:Brad Mulcahey Title:Chief Financial Officer and Treasurer
BOW Breaking Stock News: Dive into BOW Ticker-Specific Updates for Smart Investing
See how BOW stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "BOW Bowhead Specialty Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.